Tag: 2020

Latest News

Global Sanfilippo Syndrome Type A (MPS IIIA) Pipeline Insight, 2020 – Insights Into the Present Clinical Development Scenario and Growth Prospects Across the Market – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Sanfilippo Syndrome Type A (MPS IIIA) – Pipeline Insight, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report outlays comprehensive insights...
Latest News

AIVITA Biomedical CEO Hans Keirstead Named to “20 in 2020” by Consulate General of Canada for Contributions to COVID-19 Research

Newsemia
IRVINE, Calif.–(BUSINESS WIRE)–AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, announced that Hans Keirstead,...
Latest News

Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a next-generation cardiovascular company, today announced the presentation of new preclinical proof-of-concept data in non-human primates that demonstrate the successful use...
Latest News

COVID-19 Pandemic Paradox: 2020 Has Fewer Deaths Than Five Years Prior

Newsemia
U.K. researchers called the decline in death rate from December 2019 to March 2020 compared to the last five years a “COVID-19 pandemic paradox.” Source...
Latest News

Emerging Non-Opioid Pharmaceuticals for Pain Management, 2020 Research Report – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Emerging Non-Opioid Pharmaceuticals for Pain Management” report has been added to ResearchAndMarkets.com’s offering. The research provides technological advances and insights across non-opioid pharmaceuticals...
Latest News

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $VBIV–VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that updated Part...
Latest News

Global Molecular Diagnostics Market (2020 to 2024) – Insights & Forecast with Potential Impact of COVID-19 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)” report has been added...
Latest News

Global Large Volume Parenteral Market (2020 to 2025) – Featuring Supramol Laboratory, Albert David & Otsuka Holdings Among Others – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Global Large Volume Parenteral (LVP) Market – Forecasts from 2020 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global market for...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World